MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Phenomenology and management of subthalamic stimulation-induced dyskinesia in a video case series of patients with isolated dystonia

    K. Dodenhoff, I. Bledsoe, M. San Luciano, M. Volz, L. Markun, P. Starr, J. Ostrem (San Francisco, CA, USA)

  • Phenotypic Heterogeneity and Variability of Nigrostriatal Dopaminergic Function in a Dopa-Responsive Dystonia

    J.J. Lin (Nantou, Taiwan)

  • Phenotypic variability of essential tremor based on the age at onset

    S. Prasad, A. Lenka, K. Jhunjhunwala, K. Bhalsing, P. Pal (Bengaluru, India)

  • Physical activity in people with Parkinson’s disease: A qualitative study

    J. McGinley, M. Danoudis, B. BIlney, M. Morris, R. Higgins (Parkville, Australia)

  • Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

  • Pilot economic evaluation of Personal KinetiGraph (PKG) for management of Parkinson’s disease in Australia

    P. Lynch, D. Jackson, D. Tilden, M. Horne (Minnetonka, MN, USA)

  • Pilot study of a new tool to optimize dopaminergic treatment in Parkinson’s disease: The OPTIPARK Scale Project

    J. Máñez Miró, F. Vivancos-Matellano, P. Martínez-Martín (Mostoles, Spain)

  • Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp

    J. Park, E. Shamim, O. Panyakaew, P. Mathew, C. Toro, J. Sackett, B. Karp, C. Lungu, K. Alter, B. Hodsdon, M. Villegas, T. Wu, O. Ahmad, P. Srivanitchapoom, S. Auh, M. (Goyang, Republic of Korea)

  • Pimavanserin Combined With Anti-Dementia Medications for Parkinson Disease Psychosis

    A. Espay, M. Guskey, N. Larsen, B. Coate, J. Vizcarra, S. Factor, J. Friedman, D. Weintraub, A. Lang (Cincinnati, OH, USA)

  • Pisa syndrome in Parkinson’s disease: Evidence for bilateral vestibulospinal dysfunction

    G. Di Lazzaro, T. Schirinzi, S. Di Girolamo, R. Di Mauro, A. Pisani (Rome, Italy)

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 177
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley